http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015258025-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c58a362565a0616bcc3901fcbf9643de
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1271
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
filingDate 2014-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54adf36911041e594e28f5749fb18f61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e183ee42a93b3206716f12b68770b25
publicationDate 2015-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2015258025-A1
titleOfInvention Liposomal lupeol acetate and the use thereof in preparing drugs for rheumatoid arthritis
abstract The present invention relates to a liposomal lupeol acetate (Lipo-LA) and its use in the treatment or prevention of rheumatoid arthritis (RA). The liposomal lupeol acetate of the present invention especially inhibits inflammatory responses and osteoclast generation (osteoclastogenesis) in the progression of rheumatoid arthritis (RA) at a half dose of the un-capsulated lupeol acetate, which may significantly reduce the incidence of RA and improve the therapeutic efficacy of lupeol acetate.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108498786-A
priorityDate 2014-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004180082-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012177754-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006025389-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007281047-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5356633-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92157
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID969516
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7005
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21584101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399905
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128635194
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126941
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399637
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID320930
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227197966
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395835
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394386
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12900948
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128794306
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399873
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64965
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227197965
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395597
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4112
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12359010
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID171548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399906

Total number of triples: 50.